ATOS
Atossa Therapeutics, Inc.Healthcare$4.85
◆ Neutral
Mkt Cap: $41.8M|Float: 8.6M|SI: 3.7%|DTC: 3.5
Data as of market close Mar 30, 2026
IV Rank
100
IV Pctl
86%
HV 20d
8238.0%
52W Range
$4-$19
ATR(14)
$0.47
Exp. Move
±24.2%
P/C Ratio
0.18
Earnings
-
GEX Positive
DEX Long
Net Put Premium
IV High
Max Pain Below
Exp. Move Wide
Low Put/Call
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 18 | ±$1.18 | ±24.2% | $3.68 | $6.03 |
| 2026-05-15 | 46 | ±$1.05 | ±21.6% | $3.80 | $5.90 |
| 2026-07-17 | 109 | ±$2.80 | ±57.7% | $2.05 | $7.65 |
| 2026-10-16 | 200 | ±$1.67 | ±34.5% | $3.18 | $6.53 |
Explore ATOS options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.